The devastating retrovirus HTLV-1 has eluded scientists for decades. Overcoming chronic funding and other challenges, ...
Our nation's efforts to focus attention on the fight both in our country and throughout the globe is important if AIDS is ...
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...
For more than 40 years, Dr. Gordon Crofoot has advanced HIV care through groundbreaking research, compassionate medicine, and ...
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activityIMC-I109V is a bispecific T cell receptor targeting ...
Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...
Patients with refractory chronic cough who received twice-daily Haduvio for 21 days had decreases in cough frequency and ...
Texas Biomed researchers find that long-term, low doses of THC mitigate many harmful side effects and inflammation caused by ...
ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback